Track FDC Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 3.57 %
Low
376.1
High
396.1
1 Month returns: 17.02 %
Low
321.3
High
396.1
1 Year returns: -7.42 %
Low
313.0
High
442.0
3 Year CAGR: 2.70 %
Low
313.0
High
658.8
5 Year CAGR: 3.53 %
Low
225.0
High
658.8
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for FDC Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
FDC Ltd. Shareholding Pattern
Quarterly breakdown of FDC Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in FDC Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of FDC Ltd.?
The current share price of FDC Ltd. is ₹ 390.45 as of 6 Nov 2026.
What is the market capitalisation of FDC Ltd.?
The market capitalisation of FDC Ltd. stands at ₹ 6,372.38 Cr.
What is the PE ratio of FDC Ltd.?
The Price-to-Earnings (PE) ratio of FDC Ltd. is 20.34 as of the latest trailing twelve months data.
What is the ROE and ROCE of FDC Ltd.?
FDC Ltd. has a Return on Equity (ROE) of 12.28% and a Return on Capital Employed (ROCE) of 12.43% as per the latest financial reports.
What is the 52-week high and low of FDC Ltd.?
The 52-week high of FDC Ltd. is - and the 52-week low is -.
What is the dividend yield of FDC Ltd.?
The dividend yield of FDC Ltd. is 1.28% based on the current market price.
What is the FII and DII holding in FDC Ltd.?
Foreign Institutional Investors (FII) hold 1.57%, Domestic Institutional Investors (DII) hold 6.54% and retail/public investors hold 19.91% of FDC Ltd. shares.
What sector does FDC Ltd. belong to?
FDC Ltd. operates in the Healthcare sector.
What is the beta of FDC Ltd.?
The beta of FDC Ltd. is 0.39, indicating its price volatility relative to the broader market. Over the past 1 year, FDC Ltd. has delivered an absolute return of -11.14%.
What is the RSI of FDC Ltd.?
The 14-day Relative Strength Index (RSI) of FDC Ltd. is 72.03, placing it in the overbought zone. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of FDC Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
PE TTM of 20.34 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -31.31%
What is P/E Ratio?
Median: 29.61
Value 20.34
-0.81673.61
Moderate ROE but improving trend
The company reported moderate ROE of 12.28% for 12-month ended 30 Sep 2026 but ROE improved by 273 bps from 1 year ago
What is ROE (FY)?
Moderate operating margin but improving trend
The company reported moderate operating margin of 13.93% for 12-month ended 30 Sep 2026 but operating margin improved by 345 bps from 1 year ago
What is Operating profit margin?
Strong EPS growth and above median growth of industry
The company delivered strong EPS growth of 38.97% for 12-month ended 30 Sep 2026 and the growth was 21.94 percentage points higher than median growth of industry
What is EPS growth (1Y)?
Low Debt to Equity, not much change from last year
The company has low Debt to Equity of 0.0 as on 30 Sep 2026 and Debt to Equity decreased marginally by 0.01 in the last 1 year
What is Debt to Equity?
Company is net cash
The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet
What is Net Debt ?
Negative
Moderate revenue growth but lower than median growth of industry
The company delivered moderate revenue growth of 10.2% for 12-month ended 30 Sep 2026 but the growth was 3.86 percentage points lower than median growth of industry
What is Sales growth (1Y)?
Median: 14.06
Value 10.2
-13.63280.47
Neutral
Company's earnings are of moderate quality
Earnings quality score of 58.7 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
58.7 / 100
Moderate dividend yield
The company has a moderate dividend yield of 1.28%
What is Dividend yield?
No red flags found!
No significant red flags found in the stock.
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Mar 2020
Jun 2020
Sep 2020
Dec 2020
Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Promoter
69.24
69.24
69.24
69.35
69.35
69.35
69.35
69.36
69.36
69.50
69.49
69.49
69.50
69.50
69.66
69.66
69.66
69.66
69.66
69.66
69.66
69.66
69.66
69.66
69.66
69.66
69.66
Indian Promoter
69.24
69.24
69.24
69.35
69.35
69.35
69.35
69.36
69.36
69.50
69.49
69.49
69.50
69.50
69.66
69.66
69.66
69.66
69.66
69.66
69.66
69.66
69.66
69.66
69.66
69.66
69.66
Foreign Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Institutions
11.26
10.42
10.39
10.20
9.73
9.24
9.16
9.93
10.38
10.41
10.76
11.53
12.07
11.18
10.54
10.19
9.59
9.24
8.65
8.75
8.93
9.58
9.25
8.59
8.69
7.71
8.17
Mutual Funds / UTI
5.21
4.72
3.40
3.52
3.74
4.11
4.45
5.25
5.69
5.88
6.60
7.54
8.03
8.88
7.93
7.54
6.69
6.51
5.79
5.87
6.18
6.98
6.63
6.21
6.23
6.25
6.48
FI/Bank/Insurance
0.36
0.35
0.24
0.23
0.23
0.17
0.12
0.12
0.12
0.12
0.12
0.11
0.11
0.09
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.07
0.06
0.06
0.06
0.06
0.06
Govt
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
FII
5.65
5.31
6.72
6.41
5.71
4.76
4.51
4.47
4.52
4.34
3.99
3.77
3.80
2.06
2.42
2.43
2.65
2.51
2.62
2.67
2.56
2.41
2.44
2.32
2.40
1.40
1.57
Other Institutions
0.03
0.04
0.04
0.04
0.04
0.20
0.08
0.08
0.05
0.08
0.05
0.11
0.13
0.16
0.12
0.15
0.18
0.14
0.17
0.14
0.12
0.12
0.12
0.00
0.00
0.00
0.05
Non-Institution
19.50
20.34
20.37
20.45
20.92
21.40
21.48
20.72
20.27
20.09
19.75
18.98
18.43
19.32
19.80
20.15
20.76
21.10
21.70
21.59
21.42
20.76
21.10
21.75
21.65
22.63
22.17
Bodies Corporate
1.92
1.84
0.77
2.99
3.02
1.71
1.84
1.89
1.86
1.83
1.79
1.74
1.71
1.80
1.79
1.81
1.77
1.81
2.53
2.50
2.56
1.98
1.88
1.95
2.01
2.07
2.26
Others (incl. Retail)
No. of shareholders
17.58
25,859
18.50
32,214
19.60
37,974
17.46
38,199
17.90
39,936
19.69
48,829
19.64
49,360
18.83
52,997
18.41
85,845
18.26
64,687
17.96
62,582
17.24
59,410
16.72
56,571
17.52
56,245
18.01
56,355
18.34
54,757
18.99
51,871
19.29
50,120
19.17
54,814
19.09
54,660
18.86
53,330
18.78
53,918
19.22
53,663
19.80
53,307
19.64
52,261
20.56
54,557
19.91
54,113
Corporate Actions
History of FDC Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.
Others
Ex-date: 13th Nov 2026Announced on: 27th Oct 2026
On Market Tender Offer.
Dividend₹ 0/share
Record date: 11th Feb 2026Ex-date: 11th Feb 2026
Announced on: 5th Feb 2026
Dividend₹ 5/share
Record date: 11th Feb 2026Ex-date: 11th Feb 2026
Announced on: 5th Feb 2026
Dividend₹ 5/share
Record date: 22nd Nov 2024Ex-date: 22nd Nov 2024
Announced on: 6th Nov 2024
Others
Ex-date: 25th Aug 2023Announced on: 9th Aug 2023
"On Market Tender Offer.Total Amount Returned INR 3100000.As of 19 September 2023 Shares repurchased 1550000000."
Company Profile
Overview of FDC Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen Sodium, Miconazole Nitrate, Timolol Maleate, Amoxycillin + Clavulanic Acid, Rupatadine Fumarate, Salbutamol Sulphate, Kaolin Light/ Pectin, among others. The Company’s product offerings cover an extensive range of categories, including anti-infectives, gastrointestinal treatments, ophthalmic, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, respiratory care, gynecology, dermatology and analgesics. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
FDC Limited is an India-based company, which is principally engaged in the business of manufacturing and trading of pharmaceutical products. The Company is specialized in manufacturing Oral Rehydration Solutions (ORS), energy drinks, antibiotics and ophthalmic therapies. Its products include Albuter...
Key personnel
Mr. Vishal D. Shah
Chief Financial Officer
Ms. Varsharani Katre
Company Secretary and Compliance Officer
Mr. Mohan Anand ChandavarkarD
Executive Chairman of the Board and Managing Director
Mr. Ameya Ashok ChandavarkarD
Chief Executive Officer - International Business, Executive Director